Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-01-24
1992-11-10
Wadell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514458, 424 10, A61K 3135, A61K 4900
Patent
active
051623668
ABSTRACT:
Enol form .delta.-lactone of diketogulonic acid (2,3,6-trihydroxy-4-oxo-2-hexen-5-olide; R-345), which is the enediol type oxidation product of ascorbic acid, and/or its sodium salt, potassium salt or calcium salt has activities of markedly reducing the toxicity of Adriamycin, reducing radiation injury, reducing liver damage induced by an organic halogen compound, and further accelerating recovery from a high blood sugar level in Alloxan-induced diabetes, using vitanim E in combination.
REFERENCES:
CA114(9):82428e.
Gardner Diane
Nissan Chemical Industries Ltd.
Wadell Frederick E.
LandOfFree
Antioxidant composition in vivo comprising enol form .delta.-lac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antioxidant composition in vivo comprising enol form .delta.-lac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antioxidant composition in vivo comprising enol form .delta.-lac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2293247